ASCPT Podcast Channel
MENU  

Tagged: PSP

Peer Review: What’s the Best Way to Organize My Review?

Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics & Systems Pharmacology, delves into why he appreciates reviews that are broken up into three sections as well as why ASCPT’s journals ask for comments to the editor as well as the reviewer.

You can access PSP’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.

ASCPT Podcast Channel
ASCPT Podcast Channel
Peer Review: What’s the Best Way to Organize My Review?
/

Peer Review: After the Review

In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics & Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision on a manuscript, and how she decides is reviewers are needed for a revised manuscript.

You can access PSP’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.

ASCPT Podcast Channel
ASCPT Podcast Channel
Peer Review: After the Review
/

Peer Review: What’s Not Helpful in a Review?

ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias.

You can access CPT’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.

ASCPT Podcast Channel
ASCPT Podcast Channel
Peer Review: What’s Not Helpful in a Review?
/

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck

On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It’s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

ASCPT Podcast Channel
ASCPT Podcast Channel
PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck
/
Copyright © 2020-2023 John Wiley & Sons, Inc. All Rights Reserved.